banner

ALR Technologies Nears Commercialization of Diabetes Management Systems

ALR Technologies (ALRT) Universal Glucose Data Upload Cable Comparison

Following an announcement earlier this month providing shareholders with an update on the commercial launch of its Health-e-Connect system for remote monitoring and chronic disease management, ALR Technologies released news today further detailing its systems, including a unique universal cable.  As part of the introduction of the universal cable, ALR provided pictures on their website.  Interested parties are encouraged to follow the link provided below to see how the universal cord streamlines data uploads for clinicians.

The press release:

ALR Technologies Completes Development Phase for Universal Internet-Based Glucose Monitoring System

ALR Technologies Inc. (OTCBB: ALRT) (the “Company”), a health information technology developer, has completed development of its HIPAA-compliant, FDA-cleared Internet-based glucose monitoring system, Health-e-Connect. In addition to the development of Health-e-Connect, the Company unveiled a first-of-its-kind universal data upload cable that is uniquely able to transfer patient data from most digital glucose meters into one glucose monitoring population management system, Health-e-Connect.



ALR Technologies is now preparing for commercial production of the universal cable in conjunction with the national sales and distribution of their Health-e-Connect System.

Compatible with most digital glucose meters produced by the nation’s top five manufacturers — Abbott, Bayer, LifeScan (Johnson & Johnson), Nipro and Roche — the Health-e-Connect system and universal data cable have already attracted the attention of frontline clinicians attending several recent national diabetes conventions. Endocrinologists, primary care physicians, and diabetes educators immediately saw the benefit of replacing multiple software platforms and data cables with one universal glucose monitoring platform and data upload cable.

“The universal cable is one of the cornerstones of the ALR Technologies system and we feel it gives us another competitive edge over others in the diabetes management space,” says Sidney Chan, Chief Executive Officer and Chairman of ALR Technologies. “Managing multiple software platforms is not practical or cost-effective for providers, and it’s not good for patients. Health-e-Connect eliminates the inefficiencies created by multiple platforms, giving providers more time to spend on direct patient care. It also gives providers the tools necessary to effectively manage entire patient populations, which is where the real opportunities lie in leveraging technology to coordinate care, improve patient outcomes, contain complications and reduce costs for widespread chronic diseases like diabetes.”

Images comparing the universal cable with current clinical practice can be viewed at: www.alrt.com/assets/images/Cable_Comparison.pdf

About ALR Technologies Inc.

ALRT Health-e-Connect System (“System”) is the principal product of the Company. HeC is a web based patient management platform for medical professionals to improve compliance and adherence of care plans of patients in their homes. The System is programmed to assist healthcare providers caring for diabetes patients. The platform will be expanded to cover patients with other chronic diseases. More information on ALR Technologies and its products can be found at http://www.alrt.com.

This release contains certain “forward-looking statements” relating to ALR Technologies’ business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words “estimate,” “expect,” “anticipate,” “believe” and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company’s quarterly filings with the Securities Exchange Commission.

Public Relations:

ALR Technologies Inc.

804-554-3500 Ext. 704

e-mail: [email protected]

ALR Technologies (ALRT) Stock Quote and News:







Disclaimer: Neither www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has been compensated three thousand dollars for one month of consultation and journalism services and to manage an investor relations/awareness program by ALR Technologies. Viper has completed prior service agreements with ALRT Technologies with full disclosure listed on our disclaimer/disclosure page. Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.

0 comments

Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

Stocks Struggle for a Reason to Move on Tuesday

Stocks Struggle for a Reason to Move on Tuesday(0)

American stocks were mixed with the Dow edging lower and the S&P 500 and Nasdaq squeaking ahead on Tuesday as a lack of conviction kept investors on the sidelines. Sentiment is torn ahead of quarterly reports starting to flow in and the euro zone’s financial turmoil as Spain is in focus in need of a

Markets End Mixed on First Day of Fourth Quarter

Markets End Mixed on First Day of Fourth Quarter(0)

A rally on Wall Street lost steam Monday afternoon following comments from Federal Reserve chairman Ben Bernanke. Stocks had started the day strong as data from the Institute for Supply Management showed that its manufacturing index climbed into expansion territory for the first time after three straight months of contraction. Traders also found solace in

Cardium Increases Product Portfolio with Acquisition of To Go Brands

Cardium Increases Product Portfolio with Acquisition of To Go Brands(0)

Cardium Therapeutics (NYSE MKT: CXM) today announced that its MedPodium® operating unit has acquired the assets, business and product portfolio of privately-held To Go Brands® to support the expansion of Cardium’s health sciences nutraceutical brand platform. To Go Brands have introduced products in a number of food, drug and mass channel retailers, and the company

Touchdown!  NFL Refs Return to Field Thursday

Touchdown! NFL Refs Return to Field Thursday(0)

Not to knock the referees that filled-in during the lock-out of NFL officials as they did a pedestrian job, but the atrocious call on Monday Night Football between the Seahawks and the Packers was just about enough of the replacements.  Today, the National Football League said that a new eight-year deal with the NFL Referees

US Markets Drift Lower Ignoring Decent Economic Data

US Markets Drift Lower Ignoring Decent Economic Data(0)

U.S. stocks drifted lower Tuesday afternoon as worries about global economic growth overshadowed positive reports on the U.S. housing market and consumer confidence. The Dow Jones Industrial average was sharply lower, by 101.37 points, to finish at 13,457.50 The S&P 500 index subtracted 15.30 points, to 1,441.59, and the Nasdaq Composite Index got bruised 43.06

read more
banner


Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.